AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5590.05M
Enterprise Value 3440.67M
Trailing P/E N/A
Forward P/E 1-5.41
PEG Ratio (5 yr expected) 10.08
Price/Sales (ttm)0.94
Price/Book (mrq)0.77
Enterprise Value/Revenue 30.70
Enterprise Value/EBITDA 62.61

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin -6.37%
Operating Margin (ttm)-7.57%

Management Effectiveness

Return on Assets (ttm)-1.86%
Return on Equity (ttm)-18.17%

Income Statement

Revenue (ttm)628.58M
Revenue Per Share (ttm)18.25
Quarterly Revenue Growth (yoy)-1.70%
Gross Profit (ttm)370.83M
EBITDA 168.95M
Net Income Avi to Common (ttm)-141.93M
Diluted EPS (ttm)-1.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)427.53M
Total Cash Per Share (mrq)12.38
Total Debt (mrq)279.38M
Total Debt/Equity (mrq)36.65
Current Ratio (mrq)2.87
Book Value Per Share (mrq)22.08

Cash Flow Statement

Operating Cash Flow (ttm)156.17M
Levered Free Cash Flow (ttm)40.14M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.21
52-Week Change 317.28%
S&P500 52-Week Change 3-6.95%
52 Week High 326.10
52 Week Low 311.95
50-Day Moving Average 316.41
200-Day Moving Average 320.45

Share Statistics

Avg Vol (3 month) 3734.64k
Avg Vol (10 day) 3381.6k
Shares Outstanding 534.61M
Float 26.08M
% Held by Insiders 11.12%
% Held by Institutions 1131.58%
Shares Short (Dec 31, 2018) 49.03M
Short Ratio (Dec 31, 2018) 414.48
Short % of Float (Dec 31, 2018) 436.09%
Short % of Shares Outstanding (Dec 31, 2018) 426.09%
Shares Short (prior month Nov 30, 2018) 49.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/3
Last Split Date 3Sep 26, 1991